Cited by 47Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesCancer Genomics and Diagnostics

Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer

Open access
SATO, KUNIAKI, MASUDA, TAKAAKI, HU, QINGJIANG, TOBO, TARO, KIDOGAMI, SHINYA, OGAWA, YUSHI, SAITO, TOMOKO, NAMBARA, SHO +10 more·2017·Anticancer Research

Abstract

BACKGROUND/AIM: Amplification of chromosome 7p (Ch.7p) is common in colorectal cancer (CRC). The aim of this study was to identify potential driver genes on Ch.7p that are overexpressed due to DNA copy number amplification and determine their clinical significance in CRC. MATERIALS AND METHODS: We identified phosphoserine phosphatase (PSPH) as a potential driver gene using a CRC dataset from The Cancer Genome Atlas (TCGA) using a bioinformatics approach. The expression of PSPH in 124 primary CRCs was examined by quantitative reverse transcription polymerase chain reaction (PCR) and immunohistochemistry. The biological effect of PSPH expression was explored by Gene Set Enrichment Analysis (GSEA) using the TCGA dataset. RESULTS: PSPH was overexpressed in tumor tissues and PSPH positively correlated with depth of invasion and distant metastasis. On multivariate analysis, high PSPH expression was an independent poor prognostic factor. These results were supported by GSEA. CONCLUSION: PSPH could be a novel prognostic biomarker with malignant potential on Ch.7p in CRC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21873/anticanres.11574

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
SATO, K., MASUDA, T., HU, Q., TOBO, T., KIDOGAMI, S., OGAWA, Y., SAITO, T., NAMBARA, S., KOMATSU, H., HIRATA, H., SAKIMURA, S., UCHI, R., HAYASHI, N., IGUCHI, T., EGUCHI, H., ITO, S., NAKAGAWA, T., & MIMORI, K.
Affiliations
  • Kyushu University (JP)
  • Kyushu University Beppu Hospital (JP)
Venue
Anticancer Research
Published
2017-05-07
Volume
37
Issue
5
Pages
2365-2371
ISSN
  • 0250-7005 (ISSN-L)
  • 1791-7530
OpenAlex
W2613203675
Cited by
46
References
7
Citations by year
2026: 3 · 2025: 8 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 1
FWCI
3.65
Type
journal article
Language
en
Open access
Locations
  • Anticancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Tokyo
  • Japan Society for the Promotion of Science (16K10543, 16K19107, 16K10397, 16K19197, 16K07177, 15K10170)
  • Institute of Medical Science, University of Tokyo
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
phosphoserine phosphatase, colorectal cancer, prognostic factors, driver genes, gene overexpression, depth of invasion, distant metastasis, poor prognosis
MeSH terms
Aged, Chromosomes, Human, Pair 7, Colon, Female, Humans, Male, Phosphoric Monoester Hydrolases, Prognosis, RNA, Messenger, Biomarkers, Tumor, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, DNA Copy Number Variations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review